S1PR2 and asthma: In murine models of ovalbumin (OVA)-induced asthma, pharmacological inhibition of S1PR2 with JTE-013 significantly reduced levels of key inflammatory cytokines, including IL-1, IL-4, IL-5, as well as serum IgE levels in BALF [126].